Ausgabe 1/2018
Inhalt (22 Artikel)
Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG)
Jame Abraham, Humberto Caldera, Robert Coleman, Anthony Elias, Matthew P. Goetz, Muaiad Kittaneh, Elyse Lower, Reshma Mahtani, E. Terry Mamounas, Mark Pegram, Hope Rugo, Lee Schwartzberg, Tiffany Traina, Chuck Vogel
Is invasion a necessary step for metastases in breast cancer?
Steven A. Narod, Victoria Sopik
GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer
Yun-Bi Ni, Julia Y. S. Tsang, Mu-Min Shao, Siu-Ki Chan, Sai-Yin Cheung, Joanna Tong, Ka-Fai To, Gary M. Tse
Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement
Timco Koopman, Henk J. Buikema, Harry Hollema, Geertruida H. de Bock, Bert van der Vegt
Impact of an embedded genetic counselor on breast cancer treatment
Holly J. Pederson, Najaah Hussain, Ryan Noss, Courtney Yanda, Colin O’Rourke, Charis Eng, Stephen R. Grobmyer
The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ
Virginie Ory, William B. Kietzman, Jacob Boeckelman, Bhaskar V. Kallakury, Anton Wellstein, Priscilla A. Furth, Anna T. Riegel
Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients
Zhenhua Fan, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Ye Xu, Yuntao Xie
Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer
Jie Cheng, Tim Holland-Letz, Markus Wallwiener, Harald Surowy, Katarina Cuk, Sarah Schott, Andreas Trumpp, Klaus Pantel, Christof Sohn, Andreas Schneeweiss, Barbara Burwinkel
Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis
Elisa García Garre, Ginés Luengo Gil, Silvia Montoro García, Enrique Gonzalez Billalabeitia, Marta Zafra Poves, Elena García Martinez, Vanessa Roldán Schilling, Esther Navarro Manzano, Alejandra Ivars Rubio, Gregory Y. H. Lip, Francisco Ayala de la Peña
Highly favorable physiological responses to concurrent resistance and high-intensity interval training during chemotherapy: the OptiTrain breast cancer trial
Sara Mijwel, Malin Backman, Kate A. Bolam, Emil Olofsson, Jessica Norrbom, Jonas Bergh, Carl Johan Sundberg, Yvonne Wengström, Helene Rundqvist
Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer
Florentia Fostira, Emmanouil Saloustros, Paraskevi Apostolou, Andromahi Vagena, Despoina Kalfakakou, Davide Mauri, Dimitrios Tryfonopoulos, Vassileios Georgoulias, Drakoulis Yannoukakos, Georgios Fountzilas, Irene Konstantopoulou
Associations of coffee consumption and caffeine intake with mammographic breast density
Lusine Yaghjyan, Graham Colditz, Bernard Rosner, Aleksandra Gasparova, Rulla M. Tamimi
Assessment of potential risk factors for breast cancer in a population in Southern Brazil
Juliana Zeni Breyer, Eliana Marcia Wendland, Natália Luiza Kops, Maira Caleffi, Luciano Serpa Hammes
Living with chronic pain: perceptions of breast cancer survivors
Ting Bao, Andrew Seidman, Qing Li, Christina Seluzicki, Victoria Blinder, Salimah H. Meghani, John T. Farrar, Jun J. Mao
Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry
Tarsha Jones, Debra Duquette, Meghan Underhill, Chang Ming, Kari E. Mendelsohn-Victor, Beth Anderson, Kara J. Milliron, Glenn Copeland, Nancy K. Janz, Laurel L. Northouse, Sonia M. Duffy, Sofia D. Merajver, Maria C. Katapodi
Adjuvant hormonal therapy for early breast cancer: an epidemiologic study of medication adherence
Charlotte Pourcelot, Emeline Orillard, Gilles Nallet, Camille Dirand, François Billion-Rey, Garance Barbier, Sarah Chouk, Samuel Limat, Philippe Montcuquet, Julie Henriques, Sophie Paget-Bailly, Amélie Anota, Loïc Chaigneau, Virginie Nerich
Trajectories of quality of life following breast cancer diagnosis
Neha G. Goyal, Beverly J. Levine, Kimberly J. Van Zee, Elizabeth Naftalis, Nancy E. Avis
Impact of chemotherapy relative dose intensity on cause-specific and overall survival for stage I–III breast cancer: ER+/PR+, HER2- vs. triple-negative
Lu Zhang, Qingzhao Yu, Xiao-Cheng Wu, Mei-Chin Hsieh, Michelle Loch, Vivien W. Chen, Elizabeth Fontham, Tekeda Ferguson
Patient-reported outcomes of catheter-based accelerated partial breast brachytherapy and whole breast irradiation, a single institution experience
Krishan R. Jethwa, Mohamed M. Kahila, Kristin C. Mara, William S. Harmsen, David M. Routman, Geralyn M. Pumper, Kimberly S. Corbin, Jeff A. Sloan, Kathryn J. Ruddy, Tina J. Hieken, Sean S. Park, Robert W. Mutter
Management and outcomes of women diagnosed with primary breast lymphoma: a multi-institution experience
Nafisha Lalani, Karen M. Winkfield, Daniel E. Soto, Beow Y. Yeap, Andrea K. Ng, Peter M. Mauch, Rachel B. Jimenez
Detailed information about chemotherapy in breast control arm might affect cognitive sequelae compared with endocrine therapy patients
Kadri Altundag